We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$11.9B
AUM Growth
+$1.64B
Cap. Flow
+$3.17B
Cap. Flow %
26.56%
Top 10 Hldgs %
6.6%
Holding
3,409
New
939
Increased
912
Reduced
776
Closed
491

Sector Composition

Rank Sector Weight
1 Financials 22.64%
2 Technology 16.18%
3 Consumer Discretionary 11.16%
4 Industrials 10.33%
5 Healthcare 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTE icon
2701
Gran Tierra Energy
GTE
$317M
$26K ﹤0.01%
2,150
-760
-26% -$9.48K
PASG icon
2702
Passage Bio
PASG
$14.1M
$26K ﹤0.01%
1,040
-1,539
-60% -$60.6K
RNAC icon
2703
Cartesian Therapeutics
RNAC
$268M
$25K ﹤0.01%
+510
New +$28K
BFX
2704
DELISTED
BowFlex Inc.
BFX
$25K ﹤0.01%
15,400
-88,800
-85% -$179K
AHPI
2705
DELISTED
Allied Healthcare Products
AHPI
$24K ﹤0.01%
17,700
-100
-0.6% -$184
BDTX icon
2706
Black Diamond Therapeutics
BDTX
$112M
$23K ﹤0.01%
14,000
-800
-5% -$2.47K
GTBP icon
2707
GT Biopharma
GTBP
$11.5M
$23K ﹤0.01%
437
-86
-16% -$6.58K
MX icon
2708
Magnachip Semiconductor
MX
$145M
$22K ﹤0.01%
+2,151
New +$28.2K
TSHA icon
2709
Taysha Gene Therapies
TSHA
$1.89B
$22K ﹤0.01%
11,000
-13,100
-54% -$47.6K
GM icon
2710
PUT
General Motors
GM
$76.8B
$19K ﹤0.01%
+12,500
New +$459K
VHC icon
2711
VirnetX Holding Corp
VHC
$63.1M
$19K ﹤0.01%
810
-235
-22% -$7.58K
VYX icon
2712
CALL
NCR Voyix
VYX
$1.14B
$19K ﹤0.01%
+32,600
New +$598K
ABTS icon
2713
Abits Group
ABTS
$4.09M
$18K ﹤0.01%
1,247
-73
-6% -$1.3K
DOCS icon
2714
Doximity
DOCS
$4.88B
$18K ﹤0.01%
+600
New +$22K
TDAY
2715
USA Today Co
TDAY
$1.06B
$18K ﹤0.01%
+11,714
New +$28.4K
OLOX
2716
Olenox Industries
OLOX
$4.5M
$18K ﹤0.01%
2
GMDA
2717
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$18K ﹤0.01%
+11,400
New +$26K
ONCT
2718
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$18K ﹤0.01%
1,015
ATCO
2719
CALL
DELISTED
Atlas Corp.
ATCO
$18K ﹤0.01%
+50,000
New +$651K
VYX icon
2720
NCR Voyix
VYX
$1.14B
$17K ﹤0.01%
+1,467
New +$26.9K
GMVD
2721
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
$16K ﹤0.01%
1,914
-1,546
-45% -$22.7K
TRQ
2722
PUT
DELISTED
Turquoise Hill Resources Ltd
TRQ
$16K ﹤0.01%
+10,000
New +$272K
GM icon
2723
General Motors
GM
$76.8B
$15K ﹤0.01%
+473
New +$17.4K
TSM icon
2724
CALL
TSMC
TSM
$2.18T
$15K ﹤0.01%
+122,000
New +$10.1M
AWH
2725
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$14K ﹤0.01%
2,607
-20
-0.8% -$215

Similar funds

Schonfeld Strategic Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Schonfeld Strategic Advisors held 3,409 positions worth $11.9B, up 16% from $10.3B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

Schonfeld Strategic Advisors deployed $3.17B of net new capital in Q3 2022, opening 939 new positions and adding to 912 existing holdings. Its largest new stake was Corebridge Financial: 3,204,461 shares worth $63.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gen Digital, an estimated $94.3M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2022 buy was Corebridge Financial: 3,204,461 shares worth $63.1M.
  • Schonfeld Strategic Advisors added most to Fidelity National Information Services in Q3 2022, an estimated $94M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2022 reduction was Gen Digital, cutting an estimated $94.3M.
  • Schonfeld Strategic Advisors fully exited UMB Financial in Q3 2022, selling an estimated $33.6M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 6.6% of its $11.9B portfolio in Q3 2022.
  • Schonfeld Strategic Advisors opened 939 new positions and closed 491 in Q3 2022.
  • Schonfeld Strategic Advisors's portfolio value rose 16% quarter-over-quarter to $11.9B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.